協和キリンの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2017/04/03 | 1,770 | 1,772 | 1,746 | 1,755 | -7 | -0.4% | 1,208,000 |
| 2017/03/31 | 1,763 | 1,781 | 1,755 | 1,762 | +23 | +1.3% | 1,560,400 |
| 2017/03/30 | 1,777 | 1,778 | 1,734 | 1,739 | -41 | -2.3% | 1,004,900 |
| 2017/03/29 | 1,767 | 1,788 | 1,765 | 1,780 | +20 | +1.1% | 1,194,900 |
| 2017/03/28 | 1,765 | 1,781 | 1,743 | 1,760 | +12 | +0.7% | 1,270,200 |
| 2017/03/27 | 1,757 | 1,762 | 1,742 | 1,748 | -20 | -1.1% | 1,271,800 |
| 2017/03/24 | 1,722 | 1,773 | 1,715 | 1,768 | +59 | +3.5% | 1,139,300 |
| 2017/03/23 | 1,687 | 1,712 | 1,678 | 1,709 | +27 | +1.6% | 662,900 |
| 2017/03/22 | 1,681 | 1,698 | 1,678 | 1,682 | -35 | -2% | 812,500 |
| 2017/03/21 | 1,704 | 1,722 | 1,695 | 1,717 | -9 | -0.5% | 727,800 |
| 2017/03/17 | 1,738 | 1,738 | 1,721 | 1,726 | -24 | -1.4% | 818,800 |
| 2017/03/16 | 1,745 | 1,764 | 1,743 | 1,750 | -12 | -0.7% | 871,700 |
| 2017/03/15 | 1,761 | 1,766 | 1,751 | 1,762 | +3 | +0.2% | 557,800 |
| 2017/03/14 | 1,759 | 1,764 | 1,748 | 1,759 | +5 | +0.3% | 601,300 |
| 2017/03/13 | 1,742 | 1,760 | 1,730 | 1,754 | +6 | +0.3% | 538,900 |
| 2017/03/10 | 1,733 | 1,757 | 1,729 | 1,748 | +50 | +2.9% | 1,630,900 |
| 2017/03/09 | 1,717 | 1,726 | 1,688 | 1,698 | +2 | +0.1% | 861,000 |
| 2017/03/08 | 1,715 | 1,715 | 1,691 | 1,696 | -29 | -1.7% | 848,200 |
| 2017/03/07 | 1,737 | 1,742 | 1,721 | 1,725 | -12 | -0.7% | 921,400 |
| 2017/03/06 | 1,740 | 1,741 | 1,722 | 1,737 | -8 | -0.5% | 782,600 |
| 2017/03/03 | 1,746 | 1,760 | 1,737 | 1,745 | +2 | +0.1% | 1,109,900 |
| 2017/03/02 | 1,720 | 1,751 | 1,719 | 1,743 | +40 | +2.3% | 1,266,700 |
| 2017/03/01 | 1,690 | 1,714 | 1,690 | 1,703 | +22 | +1.3% | 835,500 |
| 2017/02/28 | 1,710 | 1,714 | 1,679 | 1,681 | +4 | +0.2% | 1,035,600 |
| 2017/02/27 | 1,668 | 1,685 | 1,660 | 1,677 | -8 | -0.5% | 693,300 |
| 2017/02/24 | 1,703 | 1,704 | 1,680 | 1,685 | -23 | -1.3% | 716,000 |
| 2017/02/23 | 1,685 | 1,708 | 1,678 | 1,708 | +21 | +1.2% | 996,300 |
| 2017/02/22 | 1,668 | 1,688 | 1,666 | 1,687 | +25 | +1.5% | 944,200 |
| 2017/02/21 | 1,650 | 1,663 | 1,649 | 1,662 | +23 | +1.4% | 510,300 |
| 2017/02/20 | 1,639 | 1,647 | 1,626 | 1,639 | -2 | -0.1% | 367,100 |
| 2017/02/17 | 1,613 | 1,642 | 1,609 | 1,641 | +9 | +0.6% | 746,600 |
| 2017/02/16 | 1,643 | 1,646 | 1,626 | 1,632 | -9 | -0.5% | 580,400 |
| 2017/02/15 | 1,645 | 1,649 | 1,631 | 1,641 | +35 | +2.2% | 901,600 |
| 2017/02/14 | 1,638 | 1,640 | 1,605 | 1,606 | -34 | -2.1% | 710,800 |
| 2017/02/13 | 1,645 | 1,651 | 1,635 | 1,640 | +9 | +0.6% | 703,500 |
| 2017/02/10 | 1,623 | 1,643 | 1,616 | 1,631 | +43 | +2.7% | 1,155,700 |
| 2017/02/09 | 1,577 | 1,594 | 1,576 | 1,588 | -3 | -0.2% | 584,400 |
| 2017/02/08 | 1,599 | 1,611 | 1,586 | 1,591 | -13 | -0.8% | 625,300 |
| 2017/02/07 | 1,593 | 1,612 | 1,590 | 1,604 | +6 | +0.4% | 808,700 |
| 2017/02/06 | 1,600 | 1,602 | 1,584 | 1,598 | +18 | +1.1% | 982,700 |
| 2017/02/03 | 1,565 | 1,587 | 1,562 | 1,580 | +19 | +1.2% | 1,063,600 |
| 2017/02/02 | 1,579 | 1,598 | 1,558 | 1,561 | -20 | -1.3% | 1,512,200 |
| 2017/02/01 | 1,551 | 1,585 | 1,536 | 1,581 | +60 | +3.9% | 1,969,600 |
| 2017/01/31 | 1,529 | 1,533 | 1,515 | 1,521 | -16 | -1% | 1,195,600 |
| 2017/01/30 | 1,545 | 1,545 | 1,525 | 1,537 | -11 | -0.7% | 1,036,500 |
| 2017/01/27 | 1,546 | 1,559 | 1,543 | 1,548 | +4 | +0.3% | 903,600 |
| 2017/01/26 | 1,538 | 1,553 | 1,527 | 1,544 | +18 | +1.2% | 1,280,800 |
| 2017/01/25 | 1,540 | 1,542 | 1,515 | 1,526 | -7 | -0.5% | 1,104,300 |
| 2017/01/24 | 1,542 | 1,560 | 1,527 | 1,533 | -8 | -0.5% | 1,027,100 |
| 2017/01/23 | 1,570 | 1,570 | 1,540 | 1,541 | -52 | -3.3% | 1,779,200 |
2051～
2100
件表示中 / 3768件
類似銘柄と比較する
現在ご覧いただいている「協和キリン」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 協和キリン | 263,900円 | -3.5% | -11.3% | 2.27% | 24.24倍 | 1.64倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
| アステラス薬 | 169,200円 | +0.9% | +380.2% | 4.61% | 23.31倍 | 2.00倍 |
|
医薬品国内２位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
| 塩野義 | 258,000円 | +20.9% | +10.6% | 2.56% | 12.20倍 | 1.61倍 |
|
抗ＨＩＶ薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
| エーザイ | 467,600円 | +0.1% | -3.4% | 3.42% | 31.79倍 | 1.57倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
| 小野薬 | 166,100円 | +0.6% | +43.3% | 4.82% | 11.65倍 | 1.00倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
市場注目の銘柄
チャート関連のコラム
